ABSTRACT
Introduction: The female sex has been systematically identified as one of the predictors of poor quality of life in patients with cirrhosis. However, the relationship between quality of life and sexual function in women with cirrhosis has not been widely studied. Aim: To determine the relationship between quality of life and sexual function in women with cirrhosis. Materials and methods: A cross-sectional observational study. Female patients aged 18 to 69 years were included. The SF-36-V2 survey assessed health-related quality of life, and the IFSF-6 evaluated sexual function. Univariate and multivariate linear regression was used to identify the relationship between quality of life and sexual function. Statistical significance was set at a p-value < 0.05. Results: 36 patients were available for analysis. The average age was 61 years. In the SF36-V2 survey, the physical component summary mean was 58, and the mental component summary mean was 56. The IFSF-6 had an average of 10. Sexual dysfunction occurred in 80% of patients. The IFSF-6 score was positively related to health-related quality of life. Factors associated with the deterioration of sexual function were age and menopause. The Child-Pugh score and body mass index were the main determinants of health-related quality of life. Conclusions: Sexual function could be a determinant of quality of life in women with cirrhosis.
Introducción: El sexo femenino se ha identificado de forma sistemática como uno de los predictores de mala calidad de vida en pacientes con cirrosis. Sin embargo, la relación de la calidad de vida con la función sexual en mujeres con cirrosis no ha sido ampliamente estudiada. Objetivo: Determinar la relación entre la calidad de vida y la función sexual de mujeres con cirrosis. Métodos: Estudio observacional de tipo transversal. Se incluyó a pacientes femeninas de 18 a 69 años. Se utilizó la encuesta SF-36-V2 para evaluar la calidad de vida relacionada con la salud y la IFSF-6 para valorar la función sexual. Para identificar la relación entre calidad de vida y función sexual se utilizó una relación lineal uni- y multivariante. La significación estadística se fijó con un valor p < 0,05. Resultados: 36 pacientes estuvieron disponibles para el análisis. La media de edad fue de 61 años. En la encuesta SF36-V2, la media del resumen del componente físico fue de 58 y la media del resumen del componente mental fue de 56. El IFSF-6 tuvo una media de 10. La disfunción sexual se presentó en un 80% de las pacientes. El puntaje IFSF-6 se relacionó de forma positiva con la calidad de vida relacionada con la salud. Los factores relacionados con deterioro de la función sexual son la edad y la menopausia. La escala Child-Pugh y el índice de masa corporal se identificaron como los principales determinantes de la calidad de vida relacionada con la salud. Conclusiones: La función sexual podría ser un determinante de calidad de vida de las mujeres con cirrosis.
ABSTRACT
Resumen OBJETIVO: Revisar el estado actual del conocimiento acerca de la asociación entre la esterilización quirúrgica femenina y la disfunción sexual en la mujer. METODOLOGIA: Estudio retrospectivo efectuado con base en la búsqueda bibliográfica de artículos publicados en inglés y español en las bases de datos de PubMed, LILACS, MEDLINE y EBSCO entre los años 1990 y 2022. Se seleccionaron artículos con estudios de cohorte, observacionales, casos y controles, revisiones bibliográficas sistemáticas, ensayos clínicos y metanálisis. RESULTADOS: Se obtuvieron 50 artículos de los que se excluyeron 38 por duplicidad, idioma diferente al inglés o español, sin relación con el tema específico o no estaban completos. Al final se incluyeron 12 artículos que cumplieron con los criterios para la revisión. CONCLUSIONES: La asociación entre esterilización quirúrgica y disfunción sexual femenina ha sido ampliamente discutida, pero poco estudiada. Los ensayos disponibles son observacionales efectuados en contextos socioculturales diversos, con desenlaces contradictorios y con limitaciones metodológicas. Los resultados obtenidos varían según el contexto sociocultural y el papel de la mujer en la sociedad donde se estudia, las creencias religiosas y el grado de escolaridad. Es necesario emprender más estudios con mejor calidad metodológica para establecer recomendaciones más precisas y, así, repercutir en la salud sexual de las mujeres.
Abstract OBJECTIVE: Review current status of knowledge about the association between female surgical sterilization and sexual dysfunction in women. METHODOLOGY: Retrospective study based on a literature search of articles published in English and Spanish in PubMed, LILACS, MEDLINE and EBSCO databases between 1990 and 2022. Articles with cohort, observational, case-control, systematic literature reviews, clinical trials and meta-analyses were selected. RESULTS: We obtained 50 articles of which 38 were excluded due to duplicity, language other than English or Spanish, unrelated to the specific topic or not complete. In the end, 12 articles that met the criteria for review were included. CONCLUSIONS: The association between surgical sterilization and female sexual dysfunction has been widely discussed, but little studied. The available trials are observational conducted in diverse sociocultural contexts, with contradictory outcomes and methodological limitations. The results obtained vary according to the sociocultural context and the role of women in the society being studied, the religious beliefs and level of schooling. More studies with better methodological quality are needed to establish more precise recommendations and thus have an impact on women's sexual health.
ABSTRACT
INTRODUÇÃO: Apesar do papel fundamental da função sexual na qualidade de vida da população, há uma escassez na literatura brasileira de instrumentos específicos para sua avaliação e que possam ser utilizados tanto para homens quanto para mulheres. A adaptação da Scale for Quality of Sexual Function (QSF), uma escala unissex, é um passo importante na obtenção de instrumentos que permitam a comparação de resultados entre diferentes populações. OBJETIVO: Descrever o processo de tradução e adaptação semântica da QSF para o português brasileiro. MÉTODOS: A adaptação do instrumento envolveu cinco fases: 1) duas traduções independentes, 2) uma versão de consenso realizada por tradutores e especialistas, 3) avaliação da versão gerada por mais um especialista que não participou das etapas anteriores, 4) retrotradução com avaliação do autor da escala original e, por fim, 5) aplicação da versão obtida em um grupo experimental. RESULTADOS: São descritas todas as etapas de adaptação do instrumento. A participação de especialistas tanto da área de saúde mental quanto de sexualidade humana, desde a primeira fase do processo, contribuiu para discussões amplas, que permitiram a melhor adequação dos itens, tanto conceitual quanto culturalmente. Participaram da aplicação experimental sujeitos de diferentes níveis de escolaridade de ambos os sexos, não sendo detectadas dificuldades na compreensão dos itens. CONCLUSÃO: Por meio dos procedimentos adotados, foi possível elaborar uma versão da QSF em português brasileiro.
INTRODUCTION: Despite the important role played by sexual function in quality of life, there is a scarcity of instruments in the Brazilian literature specifically designed to assess this aspect, and especially of instruments that can be used with both men and women. The adaptation of the Scale for Quality of Sexual Function (QSF), a unisex scale, is an important step in the production of instruments that allow to compare results obtained in different populations. OBJECTIVE: To describe the translation and semantic adaptation of the QSF into Brazilian Portuguese. METHODS: Instrument adaptation involved five phases: 1) two independent translations, 2) a consensual version produced by translators and experts, 3) evaluation of this version by a different expert, not involved in the previous phases, 4) back translation with evaluation by the author of the original scale, and, finally, 5) application of the final Brazilian Portuguese version in a experimental group. RESULTS: All stages of the adaptation process are described. The participation of experts from the fields of both mental health and human sexuality since the first stage of the process contributed to broader discussions, which allowed to achieve the best possible adequacy for each item, both conceptually and culturally. The experimental application of the final, adapted version of the scale involved both men and women with different educational backgrounds and levels. No difficulties were faced by this group in understanding the items included in the scale. CONCLUSION: The procedures and process herein described successfully allowed to develop a Brazilian Portuguese version of the QSF.
ABSTRACT
PURPOSE: We assessed the impact of treatment modalities, such as radical prostatectomy or external beam radiation therapy, for prostate cancer on the health related quality of life (HRQoL) and sexual function of patients. MATERIALS AND METHODS: 137 eligible patients, with localized or locally advanced prostate cancer, were enrolled from two treatment groups: radical prostatectomy (RP) and external beam radiation therapy (EBRT). To compare changes in the HRQoL and sexual function after treatment with these two modalities, an interview or postal survey was performed for the patients that were followed up at least 12 months after treatment. Finally, 57 patients (RP 34 and EBRT 23) were eligible to remain on the study. Standardized questionnaires, including the EORTC QLQ-C30 (version 3.0) and QLQ-PR25, for evaluation of HRQoL, and the International Index of Erectile Function (IIEF), for sexual function, were employed. RESULTS: On global health status and functional scales, the progression in the mean scores between the baseline and treatment were worse in the PR group. The PR group also had worse urinary incontinence, erection and ejaculation problems than the EBRT group. EBRT was associated with adverse bowel function. The IIEF demonstrated significant changes between the baseline and post-treatment scores across all five domains with the two treatment modalities, especially with a RP. CONCLUSIONS: The majority of prostate cancer patients were unable to return to functional sexual activity after both a RP and EBRT. The assignment of patients to the two treatment modalities entails different risks of urinary leakage and bowel dysfunction. These findings will help facilitate counseling, with regard to sexual function and HRQoL expectations, for prostate cancer patients.
Subject(s)
Humans , Male , Counseling , Ejaculation , Prostate , Prostatectomy , Prostatic Neoplasms , Quality of Life , Surveys and Questionnaires , Radiotherapy , Sexual Behavior , Sexual Dysfunctions, Psychological , Urinary Incontinence , Weights and MeasuresABSTRACT
PURPOSE: The aim of this study was to evaluate the efficacy of functional magnetic stimulation (FMS) therapy on the lower urinary tract symptoms (LUTSs) and sexual function in female patients with stress urinary incontinence (SUI). MATERIALS AND METHODS: 39 sexually active women, with SUI treated by FMS therapy, were studied. Before treatment, female bladder questionnaires and a visual analog scale test (VAT) were used to acquire information relating to LUTS. Questions were asked about sexual function using the female sexual function index (FSFI). Treatments were performed for 20 minutes, twice a week, for 6 weeks. After treatment, the same questionnaires were repeated at 3, 6 and 12 months. The patients were divided into two groups: those with cured or improved SUI symptoms were defined as the success group, with the remainder defined as the failure group. The VAT scores of LUTSs, the domain scores and full scale scores of FSFI were analyzed. RESULTS: The success and failure groups comprised of 25 (64%) and 14 (36%) patients, respectively. In both groups, the frequency, urge incontinence and dysuria were improved. The VAT score for the overall satisfaction was significantly decreased in the success group only (p<0.05). In the success group, the domain score for 'satisfaction' in the FSFI was significantly increased (p<0.05). The full scale scores of the FSFI were significantly increased in the success group only (p<0.05). CONCLUSIONS: These results show that FMS therapy improves some LUTSs and sexual functions, with the correction of SUI symptom. Therefore, FMS therapy could be considered as a primary therapy in SUI women with LUTSs and sexual impairment.